aminoglutethimide and Liver Neoplasms
aminoglutethimide has been researched along with Liver Neoplasms in 7 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Liver Neoplasms: Tumors or cancer of the LIVER.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years." | 9.05 | Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982) |
| "Aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily was used to treat 76 postmenopausal women with advanced breast cancer." | 7.67 | Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Cantwell, BM; Dawes, PJ; Evans, RG; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986) |
| "A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years." | 5.05 | Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982) |
| "Aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily was used to treat 76 postmenopausal women with advanced breast cancer." | 3.67 | Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Cantwell, BM; Dawes, PJ; Evans, RG; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986) |
| "42 patients with metastatic breast carcinoma were treated with aminoglutethimide, which inhibits adrenal steroid hormone synthesis." | 1.26 | Aminoglutethimide in treatment of metastatic breast carcinoma. ( Fahmy, DR; Fitzharris, BM; Ford, HT; Gazet, JC; McKinna, JA; Nash, AG; Neville, AM; Powles, TJ; Smith, IE, 1978) |
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Mustacchi, G | 1 |
| Muggia, M | 1 |
| Milani, S | 1 |
| Ceccherini, R | 1 |
| Leita, ML | 1 |
| Dellach, C | 1 |
| Gale, KE | 1 |
| Coombes, RC | 2 |
| Chilvers, C | 1 |
| Dowsett, M | 1 |
| Gazet, JC | 3 |
| Ford, HT | 3 |
| Bettelheim, R | 1 |
| Gordon, C | 1 |
| Smith, IE | 4 |
| Zava, D | 1 |
| Powles, TJ | 3 |
| Harmer, C | 1 |
| Jones, M | 1 |
| McKinna, JA | 2 |
| Fitzharris, BM | 1 |
| Fahmy, DR | 1 |
| Nash, AG | 1 |
| Neville, AM | 1 |
| Adshead, F | 1 |
| De Graeff, A | 1 |
| Mansi, JL | 1 |
| Thomas, DM | 1 |
| Harris, AL | 1 |
| Cantwell, BM | 1 |
| Sainsbury, JR | 1 |
| Needham, G | 1 |
| Evans, RG | 1 |
| Dawes, PJ | 1 |
| Wilson, R | 1 |
| Farndon, J | 1 |
Trials
2 trials available for aminoglutethimide and Liver Neoplasms
| Article | Year |
|---|---|
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone | 2002 |
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; | 1982 |
Other Studies
5 other studies available for aminoglutethimide and Liver Neoplasms
| Article | Year |
|---|---|
Treatment of advanced breast cancer with aminoglutethimide: a 14-year experience.
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Dexamethasone; Drug Evaluation; Female; Hormones | 1982 |
Aminoglutethimide in the management of advanced breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neo | 1980 |
Aminoglutethimide in treatment of metastatic breast carcinoma.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neopl | 1978 |
Small cell carcinoma of the prostate: implications for management.
Topics: Adenocarcinoma; Aminoglutethimide; Bone Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubi | 1991 |
Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Resp | 1986 |